Effect of oral contraceptives over 1-year on change in body composition profiles of women with polycystic ovary syndrome: A cohort study
Fertility and Sterility Sep 13, 2017
Kim Y, et al. - The impact of oral contraceptives (OC) over 1-year on the change in endocrine, metabolic and body composition profiles of women with polycystic ovary syndrome (PCOS) are assessed in this study. OC use more than 1 year could change androgen activity, lipid profiles and body composition for muscle and fat in PCOS women with normal BMI.
Methods
- For this research, they performed a cohort study.
- Total 187 of women with BMI<25 Kg/m2 and PCOS by Rotterdam criteria were selected in this study.
- In this study, all subjective were follow-up to check endocrine, metabolic and body composition profiles with 1-year OC use.
- Endocrine and metabolic profiles were examined by serum sample and body composition profiles were checked utilizing multi-frequency bioelectrical impedance examination.
- Information were examined by Paired t-test and McNemar test where appropriate.
Results
- In this study, after 1-year utilization of OC, SHBG (100.6±95.6 nmol/L vs. 171.5±52.1 nmol/L, P=0.002) and DHEAs (192.3±88.4 μg/dL vs. 228.8±110.6 μg/dL, P=0.002) were increased, and testosterone (0.9±0.5 ng/mL vs. 0.6±0.4 ng/mL, P<0.001), 17-α-OHP (2.3±1.6 ng/mL vs. 1.2±0.7 ng/mL, P<0.001) and AMH (12.5±10.0 ng/mL vs. 10.8±8.5 ng/mL, P=0.011) were reduced.
- Utilizing 1-year OC increased total cholesterol (195.2±33.5 mg/dL vs. 201.8±32.5 mg/dL, P=0.007) and 25-OH vitamin D (16.2±9.5 ng/mL vs. 21.6±14.8 ng/mL, P=0.039).
- For body composition profiles, protein mass (10.3±1.1 Kg vs. 10.1±1.1 Kg, P=0.004), mineral mass (2.4±0.2 Kg vs. 2.3±0.2 Kg, P=0.004), muscle mass (38.5±4.0 Kg vs. 37.7±4.1 Kg, P=0.004), fat free mass (40.8±4.2 Kg vs. 40.1±4.3 Kg, P=0.006) and basal metabolic rate (1364.5±102.0 Kcal vs. 1330.9±107.0 Kcal, P<0.001) were reduced with 1-year OC use.
- With treatment of 1-year OC utilization, the proportion of women with abnormal free androgen index (≥5) was reduced 48.6% to 21.4% (P<0.001).
- The proportion of women with abnormal HOMA-IR (>2) and abnormal percent body fat (>28%) were similar (52.9% vs. 57.1% and 34.3% vs. 31.4%, P>0.05 in both).
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries